House of Representatives

KEI Letter to US House Oversight Committee on NIH Misconduct and Lack of Transparency

Posted on by Claire Cassedy

On July 22, 2019, Knowledge Ecology International submitted a letter to the US House of Representative’s Committee on Oversight and Reform regarding the National Institutes of Health’s (NIH) lack of transparency in its exclusive licensing processes. Prior to executing an… Continue Reading →

US, AU and CA try to block WTO LDC drug patent waiver because PhRMA’s not happy enough with the TPP

Posted on by Thiru

Members of the World Trade Organization (WTO) meet this week in Geneva (15 October 2015 – 16 October 2015) to decide if the poorest countries on earth are exempt from WTO rules for pharmaceutical patents. The WTO’s TRIPS Council is expected to make a decision in respect of the request of the LDC Group’s request for indefinite exemption from TRIPS obligations on pharmaceutical patents. Continue Reading →